Clinical Trial Update: Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating using drug levels and resistance testing to tailor anti-HIV drug combinations in patients with drug-resistant HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED